🇺🇸 FDA

Drug profile · INN

sparsentan

FILSPARI

approved C09XX01
US status
approved
Patents linked
0
News articles
1

Quick answer

sparsentan (FILSPARI) is an FDA-listed pharmaceutical active ingredient. Associated with Travere Therapeutics. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sparsentan
Brand FILSPARI
Route ORAL
Formulation TABLET
ATC code C09XX01
Originator Travere Therapeutics

Frequently asked questions

What is sparsentan?

sparsentan (FILSPARI) is an FDA-listed pharmaceutical active ingredient. Associated with Travere Therapeutics. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sparsentan?

FILSPARI is a marketed brand name for sparsentan. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sparsentan?

sparsentan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.